Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: melanoma

7/20/2018

It’s way too soon to know if melanoma blood test will save ‘thousands of lives’

9/12/2017

HealthDay cautiously reports results of Opdivo melanoma study

7/13/2017

It’s misleading to call results from phase 1 trials with 6 and 13 patients a ‘cancer breakthrough’

5/1/2017

‘Game-changer, Holy Grail, groundbreaking’ used in Philly Inquirer story on phase 1 trial

12/21/2016

Reuters Health briefly but aptly reports survey findings of partner-assisted skin exams for melanoma survivors

5/24/2016

Except for presidential anecdote, NBC story on new melanoma drug was well-balanced

11/2/2015

Coverage of virus-based cancer treatment skimps on cautions and key outcomes

6/2/2015

Keytruda and colon cancer: coverage of benefits not balanced with harms and cost info

5/29/2015

Survival statistic unbalances coverage of virus-based melanoma therapy

1 5/18/2015

Rosy CBS report on vitamin study lacks meaningful description of skin cancer impact